Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium

Area of Science:

• Pharmacology
• Cardiology
• Electrophysiology

Background:

• Class III antiarrhythmic drugs are crucial for managing cardiac arrhythmias.
• The effects of ambasilide on human atrial repolarization were previously unknown.
• Understanding ambasilide's mechanism is vital for its clinical application.

Purpose of the Study:

• To investigate the effects of ambasilide on human atrial action potentials.
• To determine the impact of ambasilide on repolarizing potassium currents.
• To assess ambasilide's potential as a novel antiarrhythmic agent.

Main Methods:

• Isolated single atrial myocytes were used to record action potentials.
• Concentration-dependent effects of ambasilide on various potassium currents (IK1, IKACh, Ito1, ISO) were measured.
• Action potential duration and repolarization phases were analyzed at different stimulation frequencies.

Main Results:

• Ambasilide concentration-dependently prolonged atrial action potential duration.
• The drug's effect on action potential duration was independent of stimulation frequency (0.5-2 Hz).
• Ambasilide inhibited IK1, IKACh, Ito1, and ISO currents with varying potencies (EC50 values provided).

Conclusions:

• Ambasilide is a novel Class III antiarrhythmic drug with a unique action profile.
• Its frequency-independent prolongation of human atrial action potential is a significant finding.
• Ambasilide represents a promising alternative to existing Class III antiarrhythmic drugs.